| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6121593 | Journal of Clinical Virology | 2012 | 6 Pages |
Abstract
Successful antiviral drug treatment suggests that clinical symptoms of these patients were due to symptomatic reactivation of CIHHV-6. Alternatively, some CIHHV-6 patients may have a reduced resistance to community-acquired HHV-6 strains due to tolerance leading to persistent infections.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
José G. Montoya, Michael N. Neely, Sudhir Gupta, Mitchell R. Lunn, Kristin S. Loomis, Joshua C. Pritchett, Bruce Polsky, Peter G. Medveczky,